BioCentury | Apr 2, 2021
Management Tracks

O’Brien to head NPC; plus moves at Frontier, Araris, Montis and more

...Hoet as CSO. Hoet joins from ImCheck Therapeutics S.A.S., where he served as CSO.Cell therapy company Kytopen Corp....
...at Google Ventures to launch his own venture firm, Byers Capital. BC Staff Lyndra Therapeutics Inc. Janux Therapeutics Inc. Frontier BioSciences Inc. Kytopen Corp. Araris...
BioCentury | May 28, 2019
Financial News

May 28 Financial Quick Takes: Alphamab Oncology raises $60M; plus $180.5M for Panacea healthcare fund and more

...Phase II testing for triple-negative breast cancer (TNBC). MIT start-up Kytopen raises $3.6M seed round Kytopen Corp....
...Inc. Genmab A/S New Horizon Health Ltd. Oxford BioMedica plc Alphamab Oncology Ltd. Lee's Pharmaceutical Holdings Ltd. Panacea Venture China Ophthalmology Focus Ltd. Kytopen Corp....
Items per page:
1 - 2 of 2
BioCentury | Apr 2, 2021
Management Tracks

O’Brien to head NPC; plus moves at Frontier, Araris, Montis and more

...Hoet as CSO. Hoet joins from ImCheck Therapeutics S.A.S., where he served as CSO.Cell therapy company Kytopen Corp....
...at Google Ventures to launch his own venture firm, Byers Capital. BC Staff Lyndra Therapeutics Inc. Janux Therapeutics Inc. Frontier BioSciences Inc. Kytopen Corp. Araris...
BioCentury | May 28, 2019
Financial News

May 28 Financial Quick Takes: Alphamab Oncology raises $60M; plus $180.5M for Panacea healthcare fund and more

...Phase II testing for triple-negative breast cancer (TNBC). MIT start-up Kytopen raises $3.6M seed round Kytopen Corp....
...Inc. Genmab A/S New Horizon Health Ltd. Oxford BioMedica plc Alphamab Oncology Ltd. Lee's Pharmaceutical Holdings Ltd. Panacea Venture China Ophthalmology Focus Ltd. Kytopen Corp....
Items per page:
1 - 2 of 2